{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:54:11Z","timestamp":1789170851762,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["Grant numbers 2017\/08320-5, 2018\/07239-2 and 2016\/03025-2"],"award-info":[{"award-number":["Grant numbers 2017\/08320-5, 2018\/07239-2 and 2016\/03025-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL-62235"],"award-info":[{"award-number":["R01-HL-62235"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"crossref","award":["(\u201cVaast Leysen Leerstoel voor Infectieziekten in Ontwikkelingslanden\u201d"],"award-info":[{"award-number":["(\u201cVaast Leysen Leerstoel voor Infectieziekten in Ontwikkelingslanden\u201d"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["grant G0A0621N"],"award-info":[{"award-number":["grant G0A0621N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying therapy is available, but corticosteroids provide some clinical benefit. Although HAM\/TSP pathogenesis is not fully elucidated, older age, female sex and higher proviral load are established risk factors. We investigated systemic cytokines and a novel chronic inflammatory marker, GlycA, as possible biomarkers of immunopathogenesis and therapeutic response in HAM\/TSP, and examined their interaction with established risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>We recruited 110 People living with HTLV-1 (PLHTLV-1, 67 asymptomatic individuals and 43 HAM\/TSP patients) with a total of 946 person-years of clinical follow-up. Plasma cytokine levels (IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-\u03b3, TNF) and GlycA were quantified by Cytometric Bead Array and <jats:sup>1<\/jats:sup>NMR, respectively. Cytokine signaling and prednisolone response were validated in an independent cohort by nCounter digital transcriptomics. We used multivariable regression, machine learning algorithms and Bayesian network learning for biomarker identification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that systemic IL-6 was positively correlated with both age (<jats:italic>r<\/jats:italic>\u2009=\u20090.50, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and GlycA (<jats:italic>r<\/jats:italic>\u2009=\u20090.45, <jats:italic>p<\/jats:italic>\u2009=\u20090.00049) in asymptomatics, revealing an \u2018inflammaging\u201d signature which was absent in HAM\/TSP. GlycA levels were higher in women (<jats:italic>p<\/jats:italic>\u2009=\u20090.0069), but cytokine levels did not differ between the sexes. IFN-\u03b3 (<jats:italic>p<\/jats:italic>\u2009=\u20090.007) and IL-17A (<jats:italic>p<\/jats:italic>\u2009=\u20090.0001) levels were increased in untreated HAM\/TSP Multivariable logistic regression identified IL-17A and proviral load as independent determinants of clinical status, resulting in modest accuracy of predicting HAM\/TSP status (64.1%), while a machine learning-derived decision tree classified HAM\/TSP patients with 90.7% accuracy. Pre-treatment GlycA and TNF levels significantly predicted clinical worsening (measured by Osame Motor Disability Scale), independent of proviral load. In addition, a poor prednisolone response was significantly correlated with higher post-treatment IFN-\u03b3 levels. Likewise, a transcriptomic IFN signaling score, significantly correlated with previously proposed HAM\/TSP biomarkers (<jats:italic>CASP5\/CXCL10\/FCGR1A\/STAT1<\/jats:italic>), was efficiently blunted by in vitro prednisolone treatment of PBMC from PLHTLV-1 and incident HAM\/TSP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>An age-related increase in systemic IL-6\/GlycA levels reveals inflammaging in PLHTLV-1, in the absence of neurological disease. IFN-\u03b3 and IL-17A are biomarkers of untreated HAM\/TSP, while pre-treatment GlycA and TNF predict therapeutic response to prednisolone pulse therapy, paving the way for a precision medicine approach in HAM\/TSP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-022-02658-w","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T14:24:01Z","timestamp":1670509441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation"],"prefix":"10.1186","volume":"19","author":[{"given":"Tatiane","family":"Assone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Maria","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"de Toledo Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Angelo","family":"Folgosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"da Silva Prates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerusa","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel E.","family":"Haziot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M. N.","family":"Marcusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via E.","family":"Dahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Vanderlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto C\u00e9sar","family":"Penalva de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Weyenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"2658_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","volume":"8","author":"Y Tagaya","year":"2017","unstructured":"Tagaya Y, Gallo RC. The exceptional oncogenicity of HTLV-1. Front Microbiol. 2017;8:1425.","journal-title":"Front Microbiol"},{"key":"2658_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/294268a0","volume":"294","author":"BJ Poiesz","year":"1981","unstructured":"Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with S\u00e9zary T-cell leukaemia. Nature. 1981;294:268\u201371.","journal-title":"Nature"},{"key":"2658_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"key":"2658_CR4","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","volume":"1","author":"CRM Bangham","year":"2015","unstructured":"Bangham CRM, Araujo A, Yamano Y, Taylor GP. HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Primer. 2015;1:15012.","journal-title":"Nat Rev Dis Primer"},{"key":"2658_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3389\/fmicb.2019.00885","volume":"10","author":"S Nozuma","year":"2019","unstructured":"Nozuma S, Jacobson S. Neuroimmunology of human T-lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol. 2019;10:885.","journal-title":"Front Microbiol"},{"issue":"1","key":"2658_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1212\/CPJ.0000000000000832","volume":"11","author":"A Araujo","year":"2021","unstructured":"Araujo A, Bangham CRM, Casseb J, Gotuzzo E, Jacobson S, Martin F, Oliveira AP, on behalf of the International Retrovirology Association, et al. Management of HAM\/TSP Systematic review and consensus-based recommendations 2019. Neurol Clin Pract. 2021;11(1):49\u201356. https:\/\/doi.org\/10.1212\/CPJ.0000000000000832.","journal-title":"Neurol Clin Pract"},{"key":"2658_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9010025","author":"RMN Marcusso","year":"2019","unstructured":"Marcusso RMN, Van Weyenbergh J, de Moura JVL, Dahy FE, de Moura Brasil Matos A, Haziot MEJ, et al. Dichotomy in fatal outcomes in a large cohort of people living with HTLV-1 in S\u00e3o Paulo, Brazil. Pathogens. 2019. https:\/\/doi.org\/10.3390\/pathogens9010025.","journal-title":"Pathogens"},{"key":"2658_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107669","volume":"218","author":"J Yamauchi","year":"2021","unstructured":"Yamauchi J, Araya N, Yagishita N, Sato T, Yamano Y. An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers. Pharmacol Ther. 2021;218: 107669.","journal-title":"Pharmacol Ther"},{"key":"2658_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjy162","volume":"13","author":"T Dierckx","year":"2019","unstructured":"Dierckx T, Verstockt B, Vermeire S, Van Weyenbergh J. GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD. J Crohns Colitis. 2019;13:389\u201394.","journal-title":"J Crohns Colitis"},{"key":"2658_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cels.2015.09.007","volume":"1","author":"SC Ritchie","year":"2015","unstructured":"Ritchie SC, W\u00fcrtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, et al. The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection. Cell Syst. 2015;1:293\u2013301.","journal-title":"Cell Syst"},{"issue":"4","key":"2658_CR11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/jcm9040970","volume":"9","author":"T Dierckx","year":"2020","unstructured":"Dierckx T, Chiche L, Daniel L, Lauwerys B, Weyenbergh JV, Jourde-Chiche N. Serum GlycA level is elevated in active systemic lupus erythematosus and correlates to disease activity and lupus nephritis severity. J Clin Med. 2020;9(4):970.","journal-title":"J Clin Med"},{"issue":"7","key":"2658_CR12","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","volume":"118","author":"PR Lawler","year":"2016","unstructured":"Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, Lee IM, Glynn RJ, Ridker PM, Buring JE, Mora S. Circulating N-linked glycoprotein acetyls and longitudinal mortality risk. Circ Res. 2016;118(7):1106\u201315.","journal-title":"Circ Res"},{"key":"2658_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244\u201354.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"2658_CR14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3389\/fimmu.2019.01965","volume":"27","author":"H Babu","year":"2019","unstructured":"Babu H, Ambikan AT, Gabriel EE, SvenssonAkusj\u00e4rvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front Immunol. 2019;27(10):1965.","journal-title":"Front Immunol"},{"issue":"3","key":"2658_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11904-021-00547-0","volume":"18","author":"SF Sieg","year":"2021","unstructured":"Sieg SF, Shive CL, Panigrahi S, Freeman ML. Probing the Interface of HIV and Inflammaging. Curr HIV\/AIDS Rep. 2021;18(3):198\u2013210.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2658_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1590\/S0100-879X2005001100011","volume":"38","author":"PA Montanheiro","year":"2005","unstructured":"Montanheiro PA, Montanheito PA, de Oliveira ACP, Posada-Vergara MP, Milagres AC, Tauil C, et al. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. Braz J Med Biol Res. 2005;38:1643\u20137.","journal-title":"Braz J Med Biol Res"},{"key":"2658_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1089\/aid.2006.22.931","volume":"22","author":"CM De Castro-Costa","year":"2006","unstructured":"De Castro-Costa CM, Ara\u00fajo AQC, Barreto MM, Takayanagui OM, Sohler MP, da Silva ELM, et al. Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM). AIDS Res Hum Retroviruses. 2006;22:931\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"13","key":"2658_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818569","volume":"23","author":"E Van Loon","year":"2022","unstructured":"Van Loon E, Lamarth\u00e9e B, Barba T, Claes S, Coemans M, de Loor H, Emonds MP, Koshy P, Kuypers D, Proost P, Senev A, Sprangers B, Tinel C, Thaunat O, Van Craenenbroeck AH, Schols D, Naesens M. Circulating donor-specific anti-HLA antibodies associate with immune activation independent of kidney transplant histopathological findings. Front Immunol. 2022;23(13): 818569.","journal-title":"Front Immunol"},{"key":"2658_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"2658_CR20","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3389\/fmicb.2018.02475","volume":"9","author":"KF Fukutani","year":"2018","unstructured":"Fukutani KF, Nascimento-Carvalho CM, Bouzas ML, Oliveira JR, Barral A, Dierckx T, et al. In situ immune signatures and microbial load at the nasopharyngeal interface in children with acute respiratory infection. Front Microbiol. 2018;9:2475.","journal-title":"Front Microbiol"},{"issue":"9","key":"2658_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1743-422X-9-171","volume":"23","author":"B Moens","year":"2012","unstructured":"Moens B, Pannecouque C, L\u00f3pez G, Talledo M, Gotuzzo E, Khouri R, Bittencourt A, Farr\u00e9 L, Galv\u00e3o-Castro B, Vandamme AM, Van Weyenbergh J. Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines. Virol J. 2012;23(9):171.","journal-title":"Virol J"},{"key":"2658_CR22","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1086\/508899","volume":"194","author":"N Kwaan","year":"2006","unstructured":"Kwaan N, Lee T-H, Chafets DM, Nass C, Newman B, Smith J, et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006;194:1557\u201364.","journal-title":"J Infect Dis"},{"issue":"8","key":"2658_CR23","first-page":"97","volume":"14","author":"SM Menezes","year":"2017","unstructured":"Menezes SM, Leal FE, Dierckx T, Khouri R, Decanine D, Silva-Santos G, Schnitman SV, Kruschewsky R, L\u00f3pez G, Alvarez C, Talledo M, Gotuzzo E, Nixon DF, Vercauteren J, Brassat D, Liblau R, Vandamme AM, Galv\u00e3o-Castro B, Van Weyenbergh J. A Fas<sup>hi<\/sup> lymphoproliferative phenotype reveals non-apoptotic fas signaling in HTLV-1-associated neuroinflammation. Front Immunol. 2017;14(8):97.","journal-title":"Front Immunol"},{"issue":"7","key":"2658_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001729","volume":"6","author":"B Moens","year":"2012","unstructured":"Moens B, Decanine D, Menezes SM, Khouri R, Silva-Santos G, Lopez G, Alvarez C, Talledo M, Gotuzzo E, de Almeida KR, Galv\u00e3o-Castro B, Vandamme AM, Van Weyenbergh J. Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-\u03b1 in HTLV-1-associated myelopathy. PLoS Negl Trop Dis. 2012;6(7): e1729.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"2658_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-11-18","volume":"29","author":"SM Menezes","year":"2014","unstructured":"Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, L\u00f3pez G, Alvarez C, Talledo M, Gotuzzo E, Vandamme AM, Galv\u00e3o-Castro B, Liblau R, Weyenbergh JV. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy\/tropical spastic paraparesis and multiple sclerosis. J Neuroinflammation. 2014;29(11):18.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"2658_CR26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3389\/fmicb.2018.00985","volume":"22","author":"FE Leal","year":"2018","unstructured":"Leal FE, Menezes SM, Costa EAS, Brailey PM, Gama L, Segurado AC, Kallas EG, Nixon DF, Dierckx T, Khouri R, Vercauteren J, Galv\u00e3o-Castro B, Saraiva Raposo RA, Van Weyenbergh J. Comprehensive antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex vivo and in vivo IFN-\u03b2 response in HTLV-1-associated neuroinflammation. Front Microbiol. 2018;22(9):985.","journal-title":"Front Microbiol"},{"key":"2658_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1426423","volume":"7","author":"R Khouri","year":"2018","unstructured":"Khouri R, Silva-Santos G, Dierckx T, Menezes SM, Decanine D, Theys K, et al. A genetic IFN\/STAT1\/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients. Oncoimmunology. 2018;7: e1426423.","journal-title":"Oncoimmunology"},{"key":"2658_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006861","author":"H Kagdi","year":"2018","unstructured":"Kagdi H, Demontis MA, Ramos JC, Taylor GP. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T-lymphotropic virus type 1 infection. PLoS Pathog. 2018. https:\/\/doi.org\/10.1371\/journal.ppat.1006861.","journal-title":"PLoS Pathog."},{"key":"2658_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nature06757","volume":"452","author":"Y Chen","year":"2008","unstructured":"Chen Y, Zhu J, Lum PY, Yang X, Pinto S, Macneil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, Leonardson A, Castellini LW, Wang S, Champy MF, Zhang B, Emilsson V, Doss S, Ghazalpour A, Horvath S, Drake TA, Lusis AJ, Schadt EE. Variations in DNA elucidate molecular networks that cause disease. Nature. 2008;452:429\u201335.","journal-title":"Nature"},{"key":"2658_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, Mcelwee J, Podtelezhnikov AA, Zhang C, Xie T, Tran L, Dobrin R, Fluder E, Clurman B, Melquist S, Narayanan M, Suver C, Shah H, Mahajan M, Gillis T, Mysore J, Macdonald ME, Lamb JR, Bennett DA, Molony C, Stone DJ, Gudnason V, Myers AJ, Schadt EE, Neumann H, Zhu J, Emilsson V. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153:707\u201320.","journal-title":"Cell"},{"key":"2658_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ebiom.2017.01.046","volume":"16","author":"Q Meng","year":"2017","unstructured":"Meng Q, Zhuang Y, Ying Z, Agrawal R, Yang X, Gomez-Pinilla F. Traumatic brain injury induces genome-wide transcriptomic, methylomic, and network perturbations in brain and blood predicting neurological disorders. EBioMedicine. 2017;16:184\u201394. https:\/\/doi.org\/10.1016\/j.ebiom.2017.01.046.","journal-title":"EBioMedicine"},{"key":"2658_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002480","volume":"8","author":"S Tattermusch","year":"2012","unstructured":"Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, et al. Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 2012;8: e1002480.","journal-title":"PLoS Pathog"},{"issue":"1","key":"2658_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/v14010136","volume":"14","author":"J Yamauchi","year":"2022","unstructured":"Yamauchi J, Tanabe K, Sato T, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Ohta Y, Matsumoto N, Kono K, Yagishita N, Araya N, Takahashi K, Kunitomo Y, Nagasaka M, Coler-Reilly A, Hasegawa Y, Araujo A, Jacobson S, Grassi MFR, Galv\u00e3o-Castro B, Bland M, Taylor GP, Martin F, Yamano Y. Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: a randomized controlled trial (HAMLET-P). Viruses. 2022;14(1):136.","journal-title":"Viruses"},{"key":"2658_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2015.06.005","volume":"69","author":"W Adriaensen","year":"2015","unstructured":"Adriaensen W, Mathe\u00ef C, Vaes B, van Pottelbergh G, Wallemacq P, Degryse J-M. Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: a regression and CART approach in the BELFRAIL study. Exp Gerontol. 2015;69:53\u201361.","journal-title":"Exp Gerontol"},{"key":"2658_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s11357-020-00247-4","volume":"42","author":"D Marcos-P\u00e9rez","year":"2020","unstructured":"Marcos-P\u00e9rez D, S\u00e1nchez-Flores M, Proietti S, Bonassi S, Costa S, Teixeira JP, et al. Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis. GeroScience. 2020;42:1451\u201373.","journal-title":"GeroScience"},{"issue":"1","key":"2658_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","volume":"20","author":"G Schierhout","year":"2020","unstructured":"Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis. 2020;20(1):133\u201343.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2658_CR37","first-page":"18","volume":"4","author":"H M\u00fchl","year":"2013","unstructured":"M\u00fchl H. Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons? Front Immunol. 2013;4(4):18.","journal-title":"Front Immunol"},{"key":"2658_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103026","volume":"61","author":"OJ McElvaney","year":"2020","unstructured":"McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O\u2019Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 2020;61: 103026.","journal-title":"EBioMedicine"},{"key":"2658_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104889","volume":"138","author":"N Ghosh","year":"2021","unstructured":"Ghosh N, Saha I, Sharma N. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities. Comput Biol Med. 2021;138: 104889.","journal-title":"Comput Biol Med"},{"issue":"12","key":"2658_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008922","volume":"14","author":"B Galv\u00e3o-Castro","year":"2020","unstructured":"Galv\u00e3o-Castro B, Rios Grassi MF, Nunes A, Galv\u00e3o-Barroso AK, Galv\u00e3o-Castro AV, L\u00edrio M, Ribeiro A, de Faria JT, Silva AL, Cerqueira M, Rangel SL, Araujo THA, Boa-Sorte N, Dourado I, Castro-Lima H, Soliani MLC. Challenges in establishing telehealth care during the COVID-19 pandemic in a neglected HTLV-1-infected population in northeastern Brazil. PLoS Negl Trop Dis. 2020;14(12): e0008922.","journal-title":"PLoS Negl Trop Dis"},{"key":"2658_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006517","volume":"4","author":"Y Yamano","year":"2009","unstructured":"Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, et al. Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS ONE. 2009;4: e6517.","journal-title":"PLoS ONE"},{"issue":"6\u20137","key":"2658_CR42","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","volume":"20","author":"AL Starling","year":"2015","unstructured":"Starling AL, Coelho-Dos-Reis JG, Peruhype-Magalh\u00e3es V, Pascoal-Xavier MA, Gon\u00e7alves DU, B\u00e9la SR, Lambertucci JR, Labanca L, Souza Pereira SR, Teixeira-Carvalho A, Ribas JG, Trindade BC, Faccioli LH, Carneiro-Proietti AB, Martins-Filho OA. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity. Biomarkers. 2015;20(6\u20137):502\u201312.","journal-title":"Biomarkers"},{"issue":"Pt 9","key":"2658_CR43","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1093\/brain\/awt183","volume":"136","author":"H Ando","year":"2013","unstructured":"Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Shimizu Y, Yudoh K, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Yamano Y. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain. 2013;136(Pt 9):2876-87.24.","journal-title":"Brain"},{"issue":"1\u20132","key":"2658_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0165-5728(98)00263-X","volume":"95","author":"T Furuya","year":"1999","unstructured":"Furuya T, Nakamura T, Fujimoto T, Nakane S, Kambara C, Shirabe S, Hamasaki S, Motomura M, Eguchi K. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J Neuroimmunol. 1999;95(1\u20132):185\u20139.","journal-title":"J Neuroimmunol"},{"key":"2658_CR45","doi-asserted-by":"crossref","unstructured":"Montanheiro PA, Penalva de Oliveira AC, Smid J, Fukumori LM, Olah I, S Duarte SAJ, Casseb J. The elevated interferon gamma production is an important immunological marker in HAM\/TSP pathogenesis. Scand J Immunol. 2009;70(4):403\u20137.","DOI":"10.1111\/j.1365-3083.2009.02291.x"},{"issue":"2","key":"2658_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002028","volume":"7","author":"FE Leal","year":"2013","unstructured":"Leal FE, Ndhlovu LC, Hasenkrug AM, Bruno FR, Carvalho KI, Wynn-Williams H, Neto WK, Sanabani SS, Segurado AC, Nixon DF, Kallas EG. Expansion in CD39+ CD4+ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis. 2013;7(2): e2028.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"2658_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006720","volume":"12","author":"LCF Romanelli","year":"2018","unstructured":"Romanelli LCF, Miranda DM, Carneiro-Proietti ABF, Mamede M, Vasconcelos HMM, Martins ML, Ferreira ASD, Rosa DVF, Paula JJ, Romano-Silva MA, Nicolato R. Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1). PLoS Negl Trop Dis. 2018;12(8): e0006720.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"2658_CR48","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/jmv.23341","volume":"84","author":"SB Santos","year":"2012","unstructured":"Santos SB, Oliveira P, Luna T, Souza A, Nascimento M, Siqueira I, Tanajura D, Muniz AL, Glesby MJ, Carvalho EM. Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection. J Med Virol. 2012;84(11):1809\u201317.","journal-title":"J Med Virol"},{"issue":"9","key":"2658_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/aid.2013.0086","volume":"29","author":"LC Romanelli","year":"2013","unstructured":"Romanelli LC, Caramelli P, Martins ML, Gon\u00e7alves DU, Proietti FA, Ribas JG, Ara\u00fajo MG, Carneiro-Proietti AB. Incidence of human T cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil. AIDS Res Hum Retroviruses. 2013;29(9):1199\u2013202.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"2658_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/civ229","volume":"61","author":"D Tanajura","year":"2015","unstructured":"Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, Orge G, Santos S, Glesby MJ, Carvalho EM. Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study. Clin Infect Dis. 2015;61(1):49\u201356.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2658_CR51","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13365-020-00847-y","volume":"26","author":"SN Ferraz","year":"2020","unstructured":"Ferraz SN, Costa GF, Carneiro Neto JA, Hebert T, de Oliveira CJV, Guerra M, Oliveira LMA, Carvalho EM. Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads. J Neurovirol. 2020;26(4):520\u20139.","journal-title":"J Neurovirol"},{"issue":"1","key":"2658_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13365-016-0484-x","volume":"23","author":"ML Martins","year":"2017","unstructured":"Martins ML, Guimar\u00e3es JC, Ribas JG, Romanelli LC, de Freitas Carneiro-Proietti AB. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM\/TSP: what is its relevance as a prognostic marker for neurologic disease? J Neurovirol. 2017;23(1):125\u201333.","journal-title":"J Neurovirol"},{"key":"2658_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002479","volume":"7","author":"T Sato","year":"2013","unstructured":"Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, et al. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. PloS Negl Trop Dis. 2013;7: e2479.","journal-title":"PloS Negl Trop Dis"},{"key":"2658_CR54","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fmicb.2018.01651","volume":"9","author":"T Sato","year":"2018","unstructured":"Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, et al. Proposal of classification criteria for HTLV-1-associated myelopathy\/tropical spastic paraparesis disease activity. Front Microbiol. 2018;9:1651.","journal-title":"Front Microbiol"},{"key":"2658_CR55","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3389\/fmicb.2019.02110","volume":"10","author":"K Tamaki","year":"2019","unstructured":"Tamaki K, Sato T, Tsugawa J, Fujioka S, Yagishita N, Araya N, et al. Cerebrospinal fluid CXCL10 as a candidate surrogate marker for HTLV-1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol. 2019;10:2110.","journal-title":"Front Microbiol"},{"issue":"6","key":"2658_CR56","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001090","volume":"8","author":"C Rosadas","year":"2021","unstructured":"Rosadas C, Zetterberg H, Heslegrave A, Haddow J, Borisova M, Taylor GP. Neurofilament light in CSF and plasma is a marker of neuronal damage in HTLV-1-associated myelopathy and correlates with neuroinflammation. Neurol Neuroimmunol Neuroinflamm. 2021;8(6): e1090.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"2658_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.737941","volume":"26","author":"FDS Souza","year":"2021","unstructured":"Souza FDS, Freitas NL, Gomes YCP, Torres RC, Echevarria-Lima J, da Silva-Filho IL, Leite ACCB, de Lima MASD, da Silva MTT, Ara\u00fajo AQC, Esp\u00edndola OM. Following the clues: usefulness of biomarkers of neuroinflammation and neurodegeneration in the investigation of HTLV-1-associated myelopathy progression. Front Immunol. 2021;26(12): 737941.","journal-title":"Front Immunol"},{"issue":"13","key":"2658_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.949516","volume":"16","author":"YCP Gomes","year":"2022","unstructured":"Gomes YCP, Freitas NL, Souza FS, Sandim V, Pereira DA, Nogueira FCS, Echevarria-Lima J, Leite ACCB, Lima MASD, Silva MTT, Ara\u00fajo AQC, Vicente ACP, Esp\u00edndola OM. Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) progression. Front Immunol. 2022;16(13): 949516.","journal-title":"Front Immunol"},{"key":"2658_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12974-021-02145-8","volume":"18","author":"SM Vasunilashorn","year":"2021","unstructured":"Vasunilashorn SM, Ngo LH, Dillon ST, et al. Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study. J Neuroinflammation. 2021;18:103.","journal-title":"J Neuroinflammation"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02658-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T14:28:41Z","timestamp":1670509721000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02658-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2658"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02658-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Board of \u201cInstituto de Infectologia Emilio Ribas\u201d, Sao Paulo-Brazil, approved the protocol (Number 07688818.2.1001.0061). Signed informed consent was obtained from all participants prior to study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have seen and approved the manuscript and agree to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}